Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

Clinical trial NCT05450432 · RECRUITING

Trial details

NCT number: NCT05450432
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2022-10-13
Primary completion: 2026-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.